Areas of further research
Studies on the development and utilization of scientific guidelines is
limited. In light of the speed of innovation and technology further
research is needed to identify optimal formats of stakeholder inclusion,
to understand the impact on research and development and approval of new
therapeutics and vaccines as well as to characterize the role of the
regulatory framework on the overall innovation system in the
pharmaceutical sector.